Home › Funds › D. E. Shaw & Co › AMRX
D. E. Shaw & Co position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)774.05K sh
Reported value held$13.40M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 18.04K | $96.00K | New |
| Q4 2021 | 158.02K | $757.00K | Add |
| Q1 2022 | 254.00K | $1.06M | Add |
| Q2 2022 | 188.93K | $601.00K | Reduce |
| Q3 2022 | 260.85K | $527.00K | Add |
| Q4 2022 | 688.84K | $1.37M | Add |
| Q1 2023 | 630.11K | $875.85K | Reduce |
| Q2 2023 | 622.23K | $1.93M | Reduce |
| Q3 2023 | 874.92K | $3.69M | Add |
| Q4 2023 | 666.04K | $4.04M | Reduce |
| Q1 2024 | 226.20K | $1.37M | Reduce |
| Q2 2024 | 89.89K | $570.83K | Reduce |
| Q1 2025 | 15.84K | $132.71K | New |
| Q2 2025 | 923.64K | $7.47M | Add |
| Q3 2025 | 1.57M | $15.67M | Add |
| Q4 2025 | 2.66M | $33.54M | Add |
| Q1 2026 | 1.72M | $21.38M | Reduce |
| Q2 2026 | 774.05K | $13.40M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMRX
- BlackRock Inc 26.56M sh · $459.79M · Q2 2026
- Vanguard Group 17.91M sh · $225.64M · Q4 2025
- Geode Capital Management 5.14M sh · $88.98M · Q2 2026
- Morgan Stanley 4.11M sh · $71.14M · Q2 2026
- Invesco Ltd 3.50M sh · $60.62M · Q2 2026
- Goldman Sachs Group 3.01M sh · $52.17M · Q2 2026
- Charles Schwab Investment Management 2.15M sh · $37.17M · Q2 2026
- Northern Trust Corp 1.91M sh · $33.15M · Q2 2026
- BNY Mellon 1.02M sh · $17.57M · Q2 2026
- Principal Global Investors 991.82K sh · $17.17M · Q2 2026
- Fidelity Management & Research (FMR) 825.12K sh · $14.28M · Q2 2026
- JPMorgan Chase & Co 795.00K sh · $13.85M · Q2 2026